Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


starting treatment
Feb 25, 2007

I tested positive last year. I believe I was infected 14 months ago. My first two labs were CD4 400 / VL 86,000; CD4 386 / VL 185,000. Based on my viral load, my doctor recommends starting treatment. I wasn't expecting this this so soon. So my questions: 1) How unusual is this? 2) Is an early high viral load indicative of a drug resistant strain? 3) Does my viral load suggest that I won't be responsive to treatment? Thanks for your answer.

Response from Dr. Young

Thanks for your post.

1) It's not unusual at all to have a CD4 count below 400 soon after infection.

2) Having a high viral load isn't indicative of drug resistance at all (as long as you're not taking antiretroviral therapy).

3) Current treatments are very effective, even among persons with high (>100,000) viral loads.

Hope this helps, BY



Previous
Epidoarl Injections
Next
define AIDS

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement